RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ConvaTec Group Stock

ConvaTec Group Revenue 2024

ConvaTec Group Revenue

2.3 B USD

Ticker

CTEC.L

ISIN

GB00BD3VFW73

WKN

A2AUD3

In 2024, ConvaTec Group's sales reached 2.3 B USD, a 7.12% difference from the 2.14 B USD sales recorded in the previous year.

The ConvaTec Group Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e2.942,17
2028e2.942,11
2027e2.7444,61
2026e2.5747,49
2025e2.4250,45
2024e2.353,26
20232.1457,06
20222.0754,35
20212.0455,41
20201.8954,81
20191.8353,23
20181.8354,40
20171.7653,16
20161.6952,60
20151.6551,64
20141.7352,52
20131.755,57

ConvaTec Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into ConvaTec Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by ConvaTec Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects ConvaTec Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of ConvaTec Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into ConvaTec Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing ConvaTec Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on ConvaTec Group’s growth potential.

ConvaTec Group Revenue, EBIT and net profit per share

DateConvaTec Group RevenueConvaTec Group EBITConvaTec Group Net Income
2029e2.9 B undefined0 undefined0 undefined
2028e2.9 B undefined739.83 M undefined507.18 M undefined
2027e2.74 B undefined680.21 M undefined459.2 M undefined
2026e2.57 B undefined575.4 M undefined407.97 M undefined
2025e2.42 B undefined523.57 M undefined351.69 M undefined
2024e2.3 B undefined465.75 M undefined304.43 M undefined
20232.14 B undefined287 M undefined130.3 M undefined
20222.07 B undefined243.7 M undefined62.9 M undefined
20212.04 B undefined210 M undefined117.6 M undefined
20201.89 B undefined230.5 M undefined112.5 M undefined
20191.83 B undefined219.5 M undefined9.8 M undefined
20181.83 B undefined290.5 M undefined221.6 M undefined
20171.76 B undefined259.6 M undefined158.4 M undefined
20161.69 B undefined180.1 M undefined-202.8 M undefined
20151.65 B undefined236.9 M undefined-93.4 M undefined
20141.73 B undefined285.8 M undefined-127.2 M undefined
20131.7 B undefined336.7 M undefined15.2 M undefined

ConvaTec Group stock margins

The ConvaTec Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ConvaTec Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ConvaTec Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the ConvaTec Group's sales revenue. A higher gross margin percentage indicates that the ConvaTec Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the ConvaTec Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the ConvaTec Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the ConvaTec Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the ConvaTec Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the ConvaTec Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

ConvaTec Group Margin History

ConvaTec Group Gross marginConvaTec Group Profit marginConvaTec Group EBIT marginConvaTec Group Profit margin
2029e57.06 %0 %0 %
2028e57.06 %25.49 %17.47 %
2027e57.06 %24.83 %16.76 %
2026e57.06 %22.35 %15.85 %
2025e57.06 %21.61 %14.51 %
2024e57.06 %20.29 %13.27 %
202357.06 %13.4 %6.08 %
202254.35 %11.76 %3.03 %
202155.41 %10.3 %5.77 %
202054.81 %12.17 %5.94 %
201953.23 %12.01 %0.54 %
201854.4 %15.86 %12.1 %
201753.16 %14.71 %8.98 %
201652.6 %10.67 %-12.01 %
201551.64 %14.35 %-5.66 %
201452.52 %16.48 %-7.33 %
201355.57 %19.8 %0.89 %

ConvaTec Group Aktienanalyse

What does ConvaTec Group do?

ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. The company was founded in the UK in 1978 and has since established a strong presence in over 100 markets worldwide. Over time, ConvaTec has become a significant leader in the healthcare industry. The company was originally founded by doctors to develop better therapies for patients with chronic diseases and wounds. It started with the development of skincare products for individuals with impaired skin barrier, such as patients with stoma and incontinence. Today, ConvaTec offers a variety of products and therapies for chronic diseases and wounds. ConvaTec operates its business in multiple product segments, each offering unique products and services. These segments include Advanced Wound Care, Infusion Devices, Stoma Care, and Continence and Critical Care. As a company, ConvaTec places a strong emphasis on innovation and research to continuously improve products and meet new medical needs. Collaborating closely with physicians, nursing staff, and patients is also emphasized. ConvaTec offers a comprehensive product portfolio. Advanced Wound Care includes a wide range of wound care products, including hydrocolloid dressings, foam dressings, and other biological collagen products. Infusion Devices consist of pump systems and catheters for administering fluids, medications, and nutrients over an extended period. Stoma Care produces products that support patients with an artificial opening to continue their daily lives as normally as possible. Continence and Critical Care provide solutions for bladder and bowel management of patients in critical situations, such as intensive care units. ConvaTec has become a leading company in the field of medical products and technologies over the years, thanks to its innovative products and a consistent focus on meeting people's needs. Through the use of new technologies and a strong focus on user feedback, ConvaTec has contributed to improving the lives of patients worldwide. Output: ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. ConvaTec Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding ConvaTec Group's Sales Figures

The sales figures of ConvaTec Group originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing ConvaTec Group’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize ConvaTec Group's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in ConvaTec Group’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about ConvaTec Group stock

How much revenue did ConvaTec Group generate this year?

ConvaTec Group has achieved a revenue of 2.3 B USD this year.

How much was the turnover of the company ConvaTec Group compared to the previous year?

The revenue of ConvaTec Group has increased by 7.12% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of ConvaTec Group?

The revenue of ConvaTec Group is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of ConvaTec Group measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of ConvaTec Group so important for investors?

The revenue of ConvaTec Group is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does ConvaTec Group pay?

Over the past 12 months, ConvaTec Group paid a dividend of 0.05 USD . This corresponds to a dividend yield of about 1.64 %. For the coming 12 months, ConvaTec Group is expected to pay a dividend of 0.05 USD.

What is the dividend yield of ConvaTec Group?

The current dividend yield of ConvaTec Group is 1.64 %.

When does ConvaTec Group pay dividends?

ConvaTec Group pays a quarterly dividend. This is distributed in the months of May, September, May, September.

How secure is the dividend of ConvaTec Group?

ConvaTec Group paid dividends every year for the past 0 years.

What is the dividend of ConvaTec Group?

For the upcoming 12 months, dividends amounting to 0.05 USD are expected. This corresponds to a dividend yield of 1.62 %.

In which sector is ConvaTec Group located?

ConvaTec Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von ConvaTec Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ConvaTec Group from 10/4/2024 amounting to 0.014 USD, you needed to have the stock in your portfolio before the ex-date on 8/22/2024.

When did ConvaTec Group pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of ConvaTec Group in the year 2023?

In the year 2023, ConvaTec Group distributed 0.046 USD as dividends.

In which currency does ConvaTec Group pay out the dividend?

The dividends of ConvaTec Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ConvaTec Group

Our stock analysis for ConvaTec Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ConvaTec Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.